| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.1 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.075 | 0.1 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.073 | 0.1 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.075 | 0.1 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.1 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |